Navigation Links
Oncolytic viruses effectively target and kill pancreatic cancer stem cells
Date:5/9/2011

Oncolytic viruses quickly infect and kill cancer stem cells, which may provide a treatment for tumors that are resistant to conventional chemotherapy and radiation, particularly pancreatic cancer, according to new research from Memorial Sloan-Kettering Cancer Center in New York. The findings are especially important since pancreatic cancer has a poor prognosis and is difficult to detect and treat at early stages.

Investigators led by Joyce Wong, MD, surgical researcher with Memorial Sloan-Kettering Cancer Center, investigated whether they could use oncolytic viruses, which are naturally occurring viruses that have been genetically engineered to be safe and express tracking genes, as a possible therapy against pancreatic cancer stem cells. These stem cells are thought to cause disease recurrence and metastasis, even after therapy, and oncolytic viruses may offer a new treatment strategy.

"What we learned is that oncolytic viruses have been engineered to selectively target cancer cells and have a low toxicity profile in animal studies," said Dr. Wong. "Targeting the cancer stem cell may enhance our ability to eradicate tumors and prevent future recurrence of disease."

While much research has been performed on isolating the cancer stem cell from various hematologic cancers, this research was based on the presence or absence of certain cell surface markers. Numerous mechanisms of how these cancer stem cells resist chemotherapy and radiation have also been examined. But to date, there have not been any studies evaluating whether genetically engineered viruses can target and kill pancreatic cancer stem cells.

Investigators sought to determine whether the viruses containing a marker gene that expresses green fluorescent protein could infect pancreatic cancer stem cells and ultimately kill the cancer stem cell. Their findings were promising and documented that viral activity was correlated with green fluorescent protein expression.

Dr. Wong added that future studies are warranted to determine whether oncolytic virus administration in vivo will help eradicate tumors and prevent future disease recurrence, and that while these initial findings are encouraging, further study is necessary to see whether oncolytic viruses will be clinically useful as a therapy.

Dr. Wong will present these data on Monday, May 9 at 10:00 a.m. CT in S505, McCormick Place.


'/>"/>

Contact: Amy Levey
alevey@gymr.com
312-791-6715
Digestive Disease Week
Source:Eurekalert

Related medicine news :

1. BUSM researchers show an oncolytic virus switches off cancer cell survival signal
2. Oncolytic viruses mediating anti-tumor immunity in human cancer patients
3. Oncos Therapeutics raises €4 million ($5.3 million) to develop oncolytic viruses into cancer treatment
4. Cold Viruses Appear Linked to Type 1 Diabetes
5. Flu Viruses Gaining Resistance, Study Confirms
6. Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers
7. Targeting hit-and-run cancer viruses
8. Researchers find function of proteins that can enhance the progression of viruses and cancer cells
9. To attack H1N1, other flu viruses, gold nanorods deliver potent payload
10. Mount Sinai discovers bone marrow plays critical role in enhancing immune response to viruses
11. Mild-mannered metabolic helper rushes to fight invading viruses, researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from ... be heartened by the industry’s current surge. But another thing that unifies them is ... At last they can simply, safely and effectively end their aroma anguish thanks to ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Emergency Physician and ... of the Outlier Leadership Series, Outliers in Writing, set to publish in summer 2017. ... Emergency Medicine at the University of Arizona College of Medicine. He also serves as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... the continuation of its strategic partnership with and platinum sponsorship of Global Spine ... the safe and effective management of complex spine deformity cases, particularly in children. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his ... the quarterback position. The former overall number one pick in the 2001 NFL Draft, ... He holds the record for the most career rushing yards by a quarterback (6,109) ...
(Date:4/24/2017)... ... April 24, 2017 , ... As part of the nationwide Days of Remembrance ... of the Holocaust and Nazi persecution, Center for Medicine after the Holocaust (CMATH) ... CMATH Champions trip to Germany and Poland next week. , The Fourth Biennial CMATH ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... R.I. , April 20, 2017  CVS ... CVS), today unveiled a new store design to ... assortment of healthier food, health-focused products and expanded ... store to help customers discover new offerings. Together ... the next evolution of the customer experience at ...
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
Breaking Medicine Technology: